Jabra Enhance Select 300 vs Otofonix Groove

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 among 65 OTC hearing aids tested, placing it in the top 25% of its category. In our testing, the Enhance Select 300 demonstrates notable strengths in speech clarity for quiet environments, scoring 0.85 points above the OTC category average. Feedback handling is excellent at 5.0/5, and own-voice comfort scores a solid 3.5/5—nearly a full point above average for the category. Music streaming performance, while above average for OTC devices, remains mixed in absolute terms at 2.6/5. The device's main limitation appears in challenging listening environments. Speech-in-noise performance scored 1.5/5, which is low in absolute terms and essentially matches the category average. Users who frequently encounter noisy restaurants, busy offices, or crowded gatherings may find this a meaningful constraint. The Enhance Select 300 is best suited for individuals who primarily need improved hearing in quieter settings such as home conversations, one-on-one meetings, or watching television. It offers reliable streaming to both iPhone and Android devices, rechargeable batteries, and hands-free functionality. Shoppers seeking stronger noise performance at this price point may want to compare alternatives like the Lucid Tala or Audicus Omni 2, which scored higher overall in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.